Stocks
Heron Therapeutics (HRTX) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -201.2 | -222.5 | -215.3 | -176.7 | -103.8 | -22.2 | ||
| Changes by years, y/y, % | +9% | +11% | -3% | -18% | -41% | -10.8% | |||
Heron Therapeutics. EBITDA US GAAP, bln rub
Heron Therapeutics. EBITDA US GAAP, changes, %
Heron Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Heron Therapeutics (HRTX) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -23.7 | -7.84 | -4.11 | -5.80 | -4.46 | -22.2 | |
| Changes by years, y/y, % | -42% | -61% | -87% | -86% | -81% | |||
| Changes by quarters, q/q, % | -43% | -67% | -48% | +41% | -23% | |||
